About This MELD Score Calculator
This MELD Score Calculator provides a comprehensive assessment of liver disease severity by calculating three major versions of the score: the original MELD, MELD-Na, and the current standard, MELD 3.0. It is an essential tool for hepatologists and transplant teams to objectively assess a patient’s 90-day mortality risk and determine their priority on the liver transplant waiting list. This calculator helps streamline the process for healthcare professionals.
The Formulas Explained
The MELD score has evolved over time to improve its predictive accuracy. All versions use a base score calculated from Bilirubin, INR, and Creatinine, with newer versions adding Sodium, Albumin, and Sex.
MELD 3.0 Formula
The current, most comprehensive version used by this MELD Score Calculator:
$$ \text{MELD 3.0} = 1.33(\text{sex}) + 4.56 \times \ln(\text{bili}) + 0.82 \times (137-\text{Na}) – [0.24 \times (137-\text{Na}) \times \ln(\text{bili})] + 9.09 \times \ln(\text{INR}) + 11.14 \times \ln(\text{creat}) + 1.85 \times (3.5-\text{alb}) – [1.83 \times (3.5-\text{alb}) \times \ln(\text{creat})] + 6 $$
Clinical Interpretation
The MELD score directly correlates with 90-day mortality risk for patients with end-stage liver disease. This calculator uses the MELD 3.0 score to provide a general risk stratification.
| MELD Score |
Risk Level |
Recommendation |
| < 15 |
Low Risk |
Lower short-term mortality risk. |
| 15 – 25 |
Intermediate Risk |
Transplant evaluation is typically considered. |
| > 25 |
High Risk |
High short-term mortality risk; high priority for transplant. |
Limitations
The MELD score is not intended for use in patients under 12 years of age, those with acute liver failure, or for predicting mortality outside the context of end-stage liver disease. The laboratory values used in the calculation are capped to prevent extreme scores from single outliers (creatinine 4.0 mg/dL for the original MELD and MELD-Na, and 3.0 mg/dL for MELD 3.0; bilirubin and INR at a minimum of 1.0).
Frequently Asked Questions (FAQ)
1. What is the main difference between MELD-Na and MELD 3.0?
MELD 3.0 is a more refined model that adds serum albumin and patient sex to the calculation. It also includes new interaction terms between variables (e.g., sodium and bilirubin), which improves its predictive accuracy, especially for female patients who were previously disadvantaged by the MELD-Na score.
2. Why is the MELD score critical for liver transplants?
It provides an objective, standardized, and validated measure of 90-day mortality risk. This “sickest first” approach ensures that organs are allocated to the patients who are in most urgent need, regardless of their time on the waiting list.
3. What does it mean if a patient is on dialysis?
For the MELD calculation, if a patient has received dialysis twice or more within the last 7 days, their serum creatinine value is automatically considered to be 4.0 mg/dL, which is the maximum value for that component. This MELD Score Calculator automatically applies this rule when the dialysis box is checked.
4. Can the MELD score predict long-term survival?
The MELD score is specifically designed and validated to predict 90-day (short-term) mortality. While a high score generally implies a poor long-term prognosis without a transplant, it is not calibrated for predicting survival beyond this 3-month window.
📖 Sources:
- Kim WR, Mannalithara A, Heimbach JK, et al. (2021). MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era. Gastroenterology, 161(6), 1887-1895.e4. PMID: 34481845.
- Biggins SW, Kim WR, Terrault NA, et al. (2006). Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology, 130(6), 1652-1660. PMID: 16697729.
- Kamath PS, Wiesner RH, Malinchoc M, et al. (2001). A model to predict survival in patients with end-stage liver disease. Hepatology, 33(2), 464-470. PMID: 11172350.
- Organ Procurement and Transplantation Network (OPTN/HRSA). MELD 3.0 adopted as the U.S. liver allocation standard (2023); scores are reported within the 6–40 range.
⚠️ Disclaimer:
This tool is for informational and educational purposes only and is not a substitute for professional clinical judgment. All treatment decisions must be made by a qualified healthcare professional considering the individual patient’s full clinical context.
